EP
Eversept Partners Portfolio holdings
AUM
$1.78B
1-Year Est. Return
97.69%
This Fund
S&P 500
1 Year Est. Return
+97.69%
AUM
$1.78B
AUM Growth
+$478M
(+37%)
Holding
122
Top Buys
| 1 | +$27.7M | |
| 2 | +$26.1M | |
| 3 | +$25.2M | |
| 4 |
Exact Sciences
EXAS
|
+$19.4M |
| 5 |
Danaher
DHR
|
+$19.1M |
Top Sells
| 1 | +$39.4M | |
| 2 | +$38.6M | |
| 3 | +$31.4M | |
| 4 |
Revvity
RVTY
|
+$22.2M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$17.3M |
Sector Composition
| 1 | Healthcare | 99.91% |
| 2 | Financials | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vera Therapeutics
VERA
$2.87B
| $156M | 8.72% |
3,072,304
+264,468
|
|
||
2
GSK
GSK
$111B
| $131M | 7.37% |
2,679,721
+559,275
|
|
||
3
United Therapeutics
UTHR
$23.5B
| $123M | 6.9% |
252,592
-628
|
|
||
|
ABVX
4
Abivax
ABVX
$8.67B
| $88.7M | 4.97% |
657,834
+231,335
|
|
||
5
Natera
NTRA
$28.2B
| $76.6M | 4.3% |
334,493
-185,151
|
|
||
6
Syndax Pharmaceuticals
SNDX
$2.13B
| $69.6M | 3.9% |
3,314,408
-152,906
|
|
||
7
Viridian Therapeutics
VRDN
$2.98B
| $55.5M | 3.11% |
1,782,235
-142,071
|
|
||
8
Vaxcyte
PCVX
$8.38B
| $55.3M | 3.1% |
1,197,722
-224,261
|
|
||
9
Travere Therapeutics
TVTX
$2.64B
| $44.9M | 2.52% |
1,174,968
-242,236
|
|
||
10
HCA Healthcare
HCA
$120B
| $44.8M | 2.51% |
95,874
-15,826
|
|
||
|
11
Danaher
DHR
$138B
| $42.6M | 2.39% |
186,262
+86,989
|
|
||
12
Ionis Pharmaceuticals
IONS
$12.5B
| $42.6M | 2.39% |
538,218
-443
|
|
||
13
Celldex Therapeutics
CLDX
$2.07B
| $39M | 2.19% |
1,434,725
+280,805
|
|
||
14
Bruker
BRKR
$5.57B
| $36.9M | 2.07% |
783,789
+96,660
|
|
||
15
Avantor
AVTR
$5.56B
| $36.4M | 2.04% |
3,176,644
+2,252,202
|
|
||
16
Community Health Systems
CYH
$469M
| $24.8M | 1.39% |
7,943,802
+993,751
|
|
||
|
17
Exact Sciences
EXAS
$19.7B
| $24.5M | 1.38% |
+241,678
|
|
||
18
BioCryst Pharmaceuticals
BCRX
$2.19B
| $23.3M | 1.31% |
2,992,895
+1,619,270
|
|
||
19
Geron
GERN
$1.04B
| $23.3M | 1.31% |
17,659,983
+5,060,981
|
|
||
20
Bio-Techne
TECH
$8.26B
| $22.2M | 1.24% |
377,405
-214,135
|
|
||
|
CDTX
21
DELISTED
Cidara Therapeutics
CDTX
| $21.8M | 1.22% |
+98,721
|
|
||
22
Insulet
PODD
$16.8B
| $21.2M | 1.19% |
74,708
+29,104
|
|
||
|
BBNX
23
Beta Bionics
BBNX
$487M
| $20.7M | 1.16% |
+678,262
|
|
||
|
24
Teva Pharmaceuticals
TEVA
$36.7B
| $20.6M | 1.16% |
660,177
-703,476
|
|
||
25
UnitedHealth
UNH
$256B
| $20.1M | 1.13% |
60,862
-1,958
|
|